T:TSXTELUS Corporation Analysis
Data as of 2026-07-16 - not real-time
CA$14.86
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
TELUS (T.TO) is trading at CA$14.86, comfortably below its 20‑day (CA$15.23), 50‑day (CA$16.33) and 200‑day (CA$18.18) simple moving averages, signaling a bearish momentum that aligns with the computed trend direction. However, the RSI of 33.8 places the stock in oversold territory, and the MACD line has just crossed above its signal line, producing a modest positive histogram and a “bullish” MACD signal, hinting at a potential short‑term rebound toward the identified resistance around CA$16.5. Fundamentally, the company’s trailing P/E of 24.8 is well above the industry average of 16.4, suggesting current pricing is stretched relative to peers, yet the forward P/E of 15.1 narrows that gap and points to earnings improvement. The dividend yield is eye‑catching at 11.4%, but the payout ratio of 278% is unsustainable, raising concerns about future dividend cuts. A massive debt load (DE/Equity ~190%) and a max drawdown of 37% add balance‑sheet pressure, while the 30‑day volatility of roughly 20% and a low beta indicate the stock can swing sharply without strong market correlation. Recent news of TELUS joining an AI consortium with major Canadian institutions could provide a new growth catalyst, especially as the firm expands its digital and health‑tech services. In this context, the model projects an upside of about 33% if the price can recover toward the median analyst target of CA$19, but downside risks remain if debt servicing or dividend sustainability issues intensify.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near strong support at CA$14.28
- Oversold RSI and bullish MACD cross
- Unsustainable dividend payout ratio
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward earnings expansion (forward P/E 15.1)
- Potential upside to CA$19 target
- Strategic AI consortium offering new growth avenues
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High debt burden limiting flexibility
- Stable cash‑flow generation from telecom core
- Diversification into health‑tech and digital services
Key Metrics & Analysis
Financial Health
Revenue Growth-0.60%
Profit Margin4.57%
P/E Ratio24.8
ROE3.74%
ROA3.30%
Debt/Equity190.14
P/B Ratio1.5
Op. Cash FlowCA$4.8B
Free Cash FlowCA$2.4B
Industry P/E16.4
Technical Analysis
TrendBearish
RSI33.8
SupportCA$14.28
ResistanceCA$16.50
MA 20CA$15.23
MA 50CA$16.33
MA 200CA$18.18
MACDBullish
VolumeDecreasing
Fear & Greed Index91.55
Valuation
Fair ValueCA$0.71
Target PriceCA$19.79
Upside/Downside33.20%
GradeFair
TypeBlend
Dividend Yield11.37%
Risk Assessment
Beta0.03
Volatility20.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.